Search for: "US v. Eliely" Results 1 - 20 of 1,259
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
17 Jul 2019, 1:38 am
Colonel Eli Lilly, Source Wikipedia Eli Lilly Jane Lambert Patents Court (Mr Justice Arnold) Eli Lilly and Co. and others v Genentech Inc. [read post]
19 Feb 2010, 3:43 am by Dennis Crouch
My recent study of BPAI written description requirement jurisprudence was prompted by reading the US Government Brief in the en banc case of Ariad v. [read post]
6 Sep 2010, 9:48 pm by Patent Docs
Noonan -- The old proverb "success has many fathers, while failure is an orphan" comes to mind when considering the Federal Circuit's decision in Eli Lilly & Co. v. [read post]
2 Jan 2014, 2:08 am
in "Bilateral Investment Treaties: Claiming Compensation from Foreign Governments under Bilateral Investment Treaties for failing to provide adequate IP Protection" 27 July 2013 I mentioned a possible claim by the US company Eli Lilly & Co. against the Canadian government under Chapter II of the agreement between the US, Canadian and Mexican governments establishing the North America Free Trade [read post]
30 Sep 2010, 9:59 pm by Patent Docs
The '826 patent claimed methods for using gemcitabine (sold by Lilly under the name GEMZAR®) for treating cancer, and the earlier '614 patent disclosed but did not... [read post]
19 Apr 2016, 7:43 am by Gene Quinn
Recently, a group of amici led by Eli Lilly filed an amici curiae brief with the United States Supreme Court in the matter of Sequenom, Inc. v. [read post]
10 Apr 2019, 8:00 am by Overhauser Law Offices, LLC
Eli Lilly claims that it is the assignee of the ‘209 patent, a method patent which was upheld as valid by the Federal Circuit in, Eli Lilly and Company v. [read post]
11 Jan 2013, 4:00 am by Paula Bremner
(Eli Lilly v Novopharm 2011 FC 1288; aff’d by bench 2012 FCA 232, appeal pending to SCC). [read post]
30 Jun 2023, 8:55 am by Lawrence Solum
This essay gives a brief overview of the Dobbs Court’s use of Ely’s famous article and discusses Ely’s critique in more detail. [read post]
4 Apr 2017, 2:51 am by Thomas Musmann
Even though IP rights have been mentioned in IIAs as protected investments for decades, Eli Lilly v. [read post]
7 Nov 2011, 12:06 pm
Lilly had challenged the patent based on the fact that there is no known use of the protein. [read post]